Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
journalStr:"WHO International Clinical Trials Registry Platform"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?lookfor=%22Pneumonia%2C+Viral%22&type=Subject&filter%5B%5D=journalStr%3A%22WHO+International+Clinical+Trials+Registry+Platform%22
/vufind/Search/Results?lookfor=%22Pneumonia%2C+Viral%22&type=Subject&filter%5B%5D=journalStr%3A%22WHO+International+Clinical+Trials+Registry+Platform%22
Search /vufind/Search2/Results?lookfor=%22Pneumonia%2C+Viral%22&type=Subject&filter%5B%5D=journalStr%3A%22WHO+International+Clinical+Trials+Registry+Platform%22
PubPharm (56)
1
Respiratory bacteria and viruses in the nasopharynx of infants and parents. : Cross-sectional surveillance study on pneumococcal serotypes and otherpathogens in nasopharyngeal samples from infants and parents performed6.5 years after introduction of pneumococcal vaccination in TheNetherlands.
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
2
Respiratory bacteria and viruses in the nasopharynx of infants and parents. : Cross-sectional surveillance study on pneumococcal serotypes and otherpathogens in nasopharyngeal samples from infants and parents performed6.5 years after introduction of pneumococcal vaccination in TheNetherlands.
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
3
CLARITHROMYCIN IN COVID-19 : ANTI-INFLAMMATORY CLARITHROMYCIN TO IMPROVE SARS-CoV-2 (COVID-19) INFECTION EARLY: THE ACHIEVE OPEN-LABEL NON-RANDOMIZED CLINICAL TRIAL
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
4
Clinical trial to Assess the Efficacy and Safety of VERU-111 for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in Patients at High Risk for Acute Respiratory Distress Syndrome (ARDS) : Phase 3, Randomized, Placebo-Controlled, Efficacy and Safety Study of VERU-111 for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in Patients at High Risk for Acute Respiratory Distress Syndrome (ARDS)
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
5
CLARITHROMYCIN IN COVID-19 : ANTI-INFLAMMATORY CLARITHROMYCIN TO IMPROVE SARS-CoV-2 (COVID-19) INFECTION EARLY: THE ACHIEVE OPEN-LABEL NON-RANDOMIZED CLINICAL TRIAL
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
6
Clinical trial to Assess the Efficacy and Safety of VERU-111 for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in Patients at High Risk for Acute Respiratory Distress Syndrome (ARDS) : Phase 3, Randomized, Placebo-Controlled, Efficacy and Safety Study of VERU-111 for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in Patients at High Risk for Acute Respiratory Distress Syndrome (ARDS)
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
7
Tocilizumab plus background therapy versus placebo plus background therapy in patients with severe COVID-19 pneumonia. : A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER STUDY TO EVALUATE THE SAFETY AND EFFICACY OF TOCILIZUMAB IN PATIENTS WITH SEVERE COVID-19 PNEUMONIA.
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
8
Tocilizumab plus background therapy versus placebo plus background therapy in patients with severe COVID-19 pneumonia. : A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER STUDY TO EVALUATE THE SAFETY AND EFFICACY OF TOCILIZUMAB IN PATIENTS WITH SEVERE COVID-19 PNEUMONIA.
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
9
Efficacy and safety of sarilumab in the early treament of hospitalized patients with mild-moderate neumonia and COVID19 infection versus standard of care : Efficacy and safety of sarilumab in the early treament of hospitalized patients with mild-moderate neumonia and COVID19 infection versus standard of care - SARICOVID
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
10
Efficacy and safety of sarilumab in the early treament of hospitalized patients with mild-moderate neumonia and COVID19 infection versus standard of care : Efficacy and safety of sarilumab in the early treament of hospitalized patients with mild-moderate neumonia and COVID19 infection versus standard of care - SARICOVID
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
1
2
3
4
5
6
Nächster »
[6]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Zeitschrift: WHO International Clinical Trials Registry Platform
Medienart
56
Aufsätze
56
E-Artikel
56
E-Ressourcen
Zeitschriftentitel
WHO International Clinical Trials Registry Plat...
Thema
56
610
54
Study Type: Interventional
32
Phase: Phase 2
30
Recruitment Status: Not yet recruiting
22
Recruitment Status: Authorised-recruitment may ...
16
Phase: Phase 3
14
Medical Condition: Severe COVID-19 pneumonia Me...
8
Medical Condition: Severe pneumonia in context ...
4
Medical Condition: COVID-19 MedDRA version: 20....
4
Recruitment Status: Completed
2
Medical Condition: Asymptomatic pneumococcal ca...
2
Medical Condition: COVID-19 (infection with SAR...
2
Medical Condition: Infection with SARS-COV-2 (=...
2
Medical Condition: Lower respiratory tract infe...
2
Medical Condition: Management of infection by S...
2
Medical Condition: MedDRA version: 21.1Level: P...
2
Medical Condition: Organ dysfunction by the nov...
2
Medical Condition: Patients with confirmed COVI...
2
Medical Condition: Pneumonia. Viral pneumonia, ...
2
Medical Condition: Possible prevention of pneum...
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
54
2020-
2
2010-2019
Erscheinungsjahr(e)
Von:
Bis:
Sprache
54
Englisch
2
Unbestimmt
Haven't found what you're looking for?
Wird geladen...